SCHEMBL24453079

SCHEMBL24453079

NC(Cc1ccccc1)C(=O)NC(CO)Cc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.69
CYP3A4 P08684 1/20 0.69
CTSC P53634 2/20 0.61
ALPI P09923 1/20 0.58
PKM P14618 1/20 0.58
PTGS1 P23219 1/20 0.58
XIAP P98170 1/20 0.58
SLC7A5 Q01650 1/20 0.58
MC4R P32245 1/20 0.55
MC3R P41968 1/20 0.55
SLC15A1 P46059 1/20 0.54
LTA4H P09960 1/20 0.51
ROCK2 O75116 3/20 0.51
ROCK1 Q13464 3/20 0.51
RPS6KA5 O75582 1/20 0.51
RPS6KA4 O75676 1/20 0.51
PRKACA P17612 1/20 0.51
GSK3A P49840 1/20 0.51
GSK3B P49841 1/20 0.51
IRAK1 P51617 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13669592 1.00 MAPK1 (0.69) MAPK1CYP3A4CTSCALPIPKM
SCHEMBL7457031 0.91 MAPK1 (0.62) MAPK1CYP3A4CTSCALPIPKM
SCHEMBL9752001 0.91 MAPK1 (0.62) MAPK1CYP3A4CTSCALPIPKM
SCHEMBL27182846 0.91 MAPK1 (0.62) MAPK1CYP3A4CTSCALPIPKM
SCHEMBL27471057 0.88 CYP3A4 (0.68) MAPK1CYP3A4CTSCLTA4H
SCHEMBL10558069 0.87 MAPK1 (0.75) MAPK1CYP3A4CTSCROCK2ROCK1
SCHEMBL9572331 0.84 CYP3A4 (0.55) MAPK1CYP3A4CTSCALPIPKM
SCHEMBL11211282 0.84 MME (0.65) MAPK1CYP3A4CTSCALPIPKM
SCHEMBL22567078 0.84 CTSC (0.58) MAPK1CYP3A4CTSCALPIPKM
SCHEMBL11211279 0.84 MME (0.65) MAPK1CYP3A4CTSCALPIPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11447448-B2 Process for the preparation of solriamfetol and salt thereof GLENMARK LIFE SCIENCES LIMITED (IN) 2022-09-20 US disclosed
US-20220162159-A1 PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF ALIVUS LIFE SCIENCES LIMITED (IN) 2022-05-26 US disclosed
US-20220162159-A1 PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF ALIVUS LIFE SCIENCES LIMITED (IN) 2022-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162159-A1 PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF TST, SPR, STS MAPK1 833/4885CYP3A4 3265/4885CTSC 1287/4885
US-11447448-B2 Process for the preparation of solriamfetol and salt thereof TST, SPR, STS MAPK1 833/4885CYP3A4 3265/4885CTSC 1287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.